| Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532321 |
NSE Symbol : ZYDUSLIFE |
P/E(TTM) : 24.31 |
|
ISIN Demat : INE010B01027 |
Div & Yield% : 0.28 |
EPS(TTM) : 43.41 |
|
Book Value(₹) : 156.19 |
Market Cap(₹Cr) : 106,197.94 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 100.60 | 101.20 | 102.40 | 102.40 | 102.40 |
| Reserves | 15,615.90 | 13,538.20 | 13,138.10 | 12,642.10 | 11,157.80 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 15,716.50 | 13,639.40 | 13,240.50 | 12,744.50 | 11,260.20 |
| Secured Loans | 0.00 | 0.00 | 500.00 | 383.90 | 356.90 |
| Unsecured Loans | 6,178.30 | 4,825.30 | 2,164.70 | 3,536.00 | 3,337.80 |
| Total Debt | 6,178.30 | 4,825.30 | 2,664.70 | 3,919.90 | 3,694.70 |
| Other Liabilities | 209.70 | 166.20 | 191.30 | 179.20 | 132.70 |
| Total Liabilities | 22,104.50 | 18,630.90 | 16,096.50 | 16,843.60 | 15,087.60 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 8,677.40 | 7,999.80 | 7,675.60 | 7,009.10 | 6,564.20 |
| Less: Accumulated Depreciation | 4,308.00 | 3,815.70 | 3,339.70 | 2,897.10 | 2,455.20 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 4,369.40 | 4,184.10 | 4,335.90 | 4,112.00 | 4,109.00 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 633.90 | 739.30 | 384.00 | 570.50 | 552.60 |
| Investments | 7,283.00 | 4,879.30 | 5,118.00 | 6,470.60 | 6,404.10 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,687.30 | 1,782.40 | 1,926.30 | 1,780.00 | 1,394.70 |
| Sundry Debtors | 4,740.10 | 3,505.30 | 2,277.70 | 1,903.80 | 2,456.70 |
| Cash and Bank Balance | 414.40 | 248.10 | 302.60 | 154.00 | 385.30 |
| Loans and Advances | 1,069.50 | 1,420.80 | 2,110.30 | 2,193.90 | 556.00 |
| Total Current Assets | 7,911.30 | 6,956.60 | 6,616.90 | 6,031.70 | 4,792.70 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1,669.20 | 1,539.30 | 1,384.50 | 1,401.70 | 1,195.10 |
| Provisions | 252.80 | 199.10 | 105.90 | 111.00 | 70.50 |
| Total CL & Provisions | 1,922.00 | 1,738.40 | 1,490.40 | 1,512.70 | 1,265.60 |
| Net Current Assets | 5,989.30 | 5,218.20 | 5,126.50 | 4,519.00 | 3,527.10 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 179.90 | 112.00 | 136.60 | 129.70 | 92.20 |
| Deferred Tax Liability | 238.20 | 306.30 | 289.70 | 237.00 | 290.50 |
| Net Deferred Tax | -58.30 | -194.30 | -153.10 | -107.30 | -198.30 |
| Other Assets | 3,887.20 | 3,804.30 | 1,285.20 | 1,278.80 | 693.10 |
| Total Assets | 22,104.50 | 18,630.90 | 16,096.50 | 16,843.60 | 15,087.60 |
| Contingent Liabilities | 111.00 | 319.90 | 1,797.10 | 1,503.90 | 3,690.30 |